Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
Shimamura T, Husain SR, Puri RK. Shimamura T, et al. Among authors: husain sr. Neurosurg Focus. 2006 Apr 15;20(4):E11. doi: 10.3171/foc.2006.20.4.6. Neurosurg Focus. 2006. PMID: 16709016 Review.
Gene therapy for cancer: regulatory considerations for approval.
Husain SR, Han J, Au P, Shannon K, Puri RK. Husain SR, et al. Cancer Gene Ther. 2015 Dec;22(12):554-63. doi: 10.1038/cgt.2015.58. Epub 2015 Nov 20. Cancer Gene Ther. 2015. PMID: 26584531 Free PMC article. Review.
Preclinical studies with IL-13PE38QQR for therapy of malignant glioma.
Joshi BH, Husain SR, Puri RK. Joshi BH, et al. Among authors: husain sr. Drug News Perspect. 2000 Dec;13(10):599-605. doi: 10.1358/dnp.2000.13.10.858450. Drug News Perspect. 2000. PMID: 12879131
Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
Kawakami K, Husain SR, Bright RK, Puri RK. Kawakami K, et al. Among authors: husain sr. Cancer Gene Ther. 2001 Nov;8(11):861-8. doi: 10.1038/sj.cgt.7700373. Cancer Gene Ther. 2001. PMID: 11773976
In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.
Kawakami K, Kawakami M, Snoy PJ, Husain SR, Puri RK. Kawakami K, et al. Among authors: husain sr. J Exp Med. 2001 Dec 17;194(12):1743-54. doi: 10.1084/jem.194.12.1743. J Exp Med. 2001. PMID: 11748276 Free PMC article.
Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
Husain SR, Joshi BH, Puri RK. Husain SR, et al. Int J Cancer. 2001 Apr 15;92(2):168-75. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1182>;2-n. Int J Cancer. 2001. PMID: 11291041
Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
Leland P, Taguchi J, Husain SR, Kreitman RJ, Pastan I, Puri RK. Leland P, et al. Among authors: husain sr. Mol Med. 2000 Mar;6(3):165-78. Mol Med. 2000. PMID: 10965493 Free PMC article.
66 results
Jump to page